| RS2540255891 |
MARS1
|
Health Risk |
Pathogenic |
Germ cell tumor of testis, Germ cell tumor of testis |
| RS2540258311 |
PYROXD1
|
Health Risk |
Pathogenic |
— |
| RS2540258330 |
PYROXD1
|
Health Risk |
Likely pathogenic |
— |
| RS2540259760 |
AICDA
|
Health Risk |
Likely pathogenic |
Hyper-IgM syndrome type 2, Hyper-IgM syndrome type 2 |
| RS2540260284 |
SCN8A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 13 |
| RS2540260370 |
SCN8A
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS2540260520 |
SCN8A
|
Health Risk |
Likely pathogenic |
Cognitive impairment with or without cerebellar ataxia, Cognitive impairment with or without cerebellar ataxia |
| RS2540260583 |
SCN8A
|
Health Risk |
Likely pathogenic |
— |
| RS2540260600 |
SCN8A
|
Health Risk |
Likely pathogenic |
Cognitive impairment with or without cerebellar ataxia, Cognitive impairment with or without cerebellar ataxia |
| RS2540262850 |
OPLAH
|
Health Risk |
Pathogenic |
5-Oxoprolinase deficiency, 5-Oxoprolinase deficiency |
| RS2540265562 |
SCN8A
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 13 |
| RS2540265567 |
SCN8A
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 13 |
| RS2540265574 |
SCN8A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2540275433 |
PEX5
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 2B, Peroxisome biogenesis disorder 2B |
| RS2540276834 |
PEX5
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 2B, Peroxisome biogenesis disorder 2B |
| RS2540277461 |
PEX5
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 2B, Peroxisome biogenesis disorder 2B |
| RS2540288652 |
MFAP5
|
Health Risk |
Likely pathogenic |
Aortic aneurysm, familial thoracic 9 |
| RS2540289128 |
PYROXD1
|
Health Risk |
Pathogenic |
— |
| RS2540290892 |
MARS1
|
Health Risk |
Pathogenic |
Autosomal recessive spastic paraplegia type 70, Autosomal recessive spastic paraplegia type 70 |
| RS2540292773 |
PEX5
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 2B, Peroxisome biogenesis disorder 2B |
| RS2540293929 |
RECQL
|
Health Risk |
Likely pathogenic |
— |
| RS2540296604 |
PEX5
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 2B, Peroxisome biogenesis disorder 2B |
| RS25403 |
FBN1
|
Health Risk |
Pathogenic |
Marfan syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS2540301979 |
SCN8A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2540302039 |
SCN8A
|
Health Risk |
Likely pathogenic |
Cognitive impairment with or without cerebellar ataxia, Cognitive impairment with or without cerebellar ataxia |
| RS2540302084 |
SCN8A
|
Health Risk |
Likely pathogenic |
SCN8A-related disorder, SCN8A-related disorder |
| RS2540302255 |
SCN8A
|
Health Risk |
Likely pathogenic |
Cognitive impairment with or without cerebellar ataxia, Cognitive impairment with or without cerebellar ataxia |
| RS2540306816 |
SCN8A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2540306984 |
SCN8A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2540306994 |
SCN8A
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-infantile DEE, Early-infantile DEE |
| RS2540307045 |
SCN8A
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 1 |
| RS2540308991 |
SCN8A
|
Health Risk |
Pathogenic/Likely pathogenic |
Early-infantile DEE, Undetermined early-onset epileptic encephalopathy |
| RS2540309039 |
SCN8A
|
Health Risk |
Likely pathogenic |
Epileptic encephalopathy, Epileptic encephalopathy |
| RS2540309047 |
SCN8A
|
Health Risk |
Likely pathogenic |
— |
| RS2540309079 |
SCN8A
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 13 |
| RS2540311940 |
MFAP5
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2540314073 |
RECQL
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2540314871 |
CEP164
|
Health Risk |
Conflicting classifications of pathogenicity |
Nephronophthisis 15, Nephronophthisis 15 |
| RS2540315721 |
SCN8A
|
Health Risk |
Pathogenic |
— |
| RS2540315938 |
CEP164
|
Health Risk |
Pathogenic |
Nephronophthisis 15, Nephronophthisis 15 |
| RS2540322042 |
PEX5
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 2B, Peroxisome biogenesis disorder 2B |
| RS2540327612 |
HK1
|
Health Risk |
Pathogenic |
— |
| RS2540327631 |
HK1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 4G, Charcot-Marie-Tooth disease type 4G |
| RS2540333608 |
SCN8A
|
Health Risk |
Likely pathogenic |
Seizures, benign familial infantile |
| RS2540333669 |
SCN8A
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 13 |
| RS2540333855 |
SCN8A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2540333858 |
SCN8A
|
Health Risk |
Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2540334634 |
SCN8A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 13 |
| RS2540334717 |
SCN8A
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-infantile DEE, Early-infantile DEE |
| RS2540335641 |
SCN8A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 13 |
| RS2540335828 |
SCN8A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2540335831 |
SCN8A
|
Health Risk |
Likely pathogenic |
— |
| RS2540339398 |
PEX5
|
Health Risk |
Likely pathogenic |
Rhizomelic chondrodysplasia punctata type 5, Rhizomelic chondrodysplasia punctata type 5 |
| RS2540340757 |
AOPEP
|
Health Risk |
Pathogenic |
Dystonia 31, Dystonia 31 |
| RS2540349751 |
HK1
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2540349993 |
HK1
|
Health Risk |
Pathogenic |
— |
| RS2540364734 |
POC1B
|
Health Risk |
Pathogenic |
— |
| RS2540369148 |
HK1
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 79, Retinitis pigmentosa 79 |
| RS2540369572 |
HK1
|
Health Risk |
Likely pathogenic |
— |
| RS2540377790 |
C5
|
Health Risk |
Pathogenic |
— |
| RS2540383441 |
CHD4
|
Health Risk |
Pathogenic |
Sifrim-Hitz-Weiss syndrome, Sifrim-Hitz-Weiss syndrome |
| RS2540383458 |
CHD4
|
Health Risk |
Likely pathogenic |
Sifrim-Hitz-Weiss syndrome, Sifrim-Hitz-Weiss syndrome |
| RS2540389596 |
DDB2
|
Health Risk |
Likely pathogenic |
Xeroderma pigmentosum, group E |
| RS2540390261 |
CHD4
|
Health Risk |
Likely pathogenic |
Sifrim-Hitz-Weiss syndrome, Sifrim-Hitz-Weiss syndrome |
| RS2540391121 |
CHD4
|
Health Risk |
Likely pathogenic |
CHD4-related disorder, CHD4-related disorder |
| RS2540392429 |
ACBD5
|
Health Risk |
Pathogenic |
— |
| RS2540393834 |
DDB2
|
Health Risk |
Likely pathogenic |
— |
| RS2540395856 |
CHD4
|
Health Risk |
Likely pathogenic |
Sifrim-Hitz-Weiss syndrome, Sifrim-Hitz-Weiss syndrome |
| RS2540395930 |
CHD4
|
Health Risk |
Likely pathogenic |
Sifrim-Hitz-Weiss syndrome, Sifrim-Hitz-Weiss syndrome |
| RS2540395935 |
CHD4
|
Health Risk |
Conflicting classifications of pathogenicity |
Sifrim-Hitz-Weiss syndrome, Sifrim-Hitz-Weiss syndrome |
| RS2540395943 |
CHD4
|
Health Risk |
Pathogenic |
Sifrim-Hitz-Weiss syndrome, Sifrim-Hitz-Weiss syndrome |
| RS2540396222 |
CHD4
|
Health Risk |
Likely pathogenic |
CHD4-related disorder, CHD4-related disorder |
| RS2540396625 |
CHD4
|
Health Risk |
Conflicting classifications of pathogenicity |
Sifrim-Hitz-Weiss syndrome, Sifrim-Hitz-Weiss syndrome |
| RS2540397438 |
CHD4
|
Health Risk |
Likely pathogenic |
Sifrim-Hitz-Weiss syndrome, Sifrim-Hitz-Weiss syndrome |
| RS2540397477 |
CHD4
|
Health Risk |
Likely pathogenic |
Sifrim-Hitz-Weiss syndrome, Sifrim-Hitz-Weiss syndrome |
| RS25404 |
FBN1
|
Health Risk |
Pathogenic/Likely pathogenic |
Marfan syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS2540400714 |
C5
|
Health Risk |
Pathogenic |
— |
| RS2540401004 |
CHD4
|
Health Risk |
Likely pathogenic |
Neonatal encephalopathy, Neonatal encephalopathy |
| RS2540403868 |
CHD4
|
Health Risk |
Likely pathogenic |
Sifrim-Hitz-Weiss syndrome, Sifrim-Hitz-Weiss syndrome |
| RS2540411694 |
CHD4
|
Health Risk |
Likely pathogenic |
Sifrim-Hitz-Weiss syndrome, Sifrim-Hitz-Weiss syndrome |
| RS2540412097 |
IRAK4
|
Health Risk |
Pathogenic |
Immunodeficiency 67, Immunodeficiency 67 |
| RS2540412258 |
CHD4
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2540412301 |
IRAK4
|
Health Risk |
Likely pathogenic |
Congenital dyserythropoietic anemia, Congenital dyserythropoietic anemia |
| RS2540412378 |
CHD4
|
Health Risk |
Likely pathogenic |
Sifrim-Hitz-Weiss syndrome, Sifrim-Hitz-Weiss syndrome |
| RS2540415610 |
PTPN11
|
Health Risk |
Likely pathogenic |
RASopathy, RASopathy |
| RS2540415621 |
PTPN11
|
Health Risk |
Likely pathogenic |
— |
| RS2540415624 |
PTPN11
|
Health Risk |
Likely pathogenic |
Noonan syndrome, Noonan syndrome |
| RS2540415689 |
PTPN11
|
Health Risk |
Likely pathogenic |
Noonan syndrome, Noonan syndrome |
| RS2540416086 |
PTPN11
|
Health Risk |
Pathogenic |
Metachondromatosis, RASopathy |
| RS2540419851 |
PTPN11
|
Health Risk |
Likely pathogenic |
Male infertility with azoospermia or oligozoospermia due to single gene mutation, Male infertility with azoospermia or oligozoospermia due to single gene mutation |
| RS2540420563 |
PTPN11
|
Health Risk |
Pathogenic |
Metachondromatosis, Metachondromatosis |
| RS2540420870 |
NOTCH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial thoracic aortic aneurysm and aortic dissection, Familial thoracic aortic aneurysm and aortic dissection |
| RS2540421105 |
NOTCH1
|
Health Risk |
Likely pathogenic |
Aortic valve disease 1, Aortic valve disease 1 |
| RS2540421448 |
NOTCH1
|
Health Risk |
Pathogenic |
Aortic valve disease 1, Aortic valve disease 1 |
| RS2540421459 |
NOTCH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Adams-Oliver syndrome 5, Adams-Oliver syndrome 5 |
| RS2540421985 |
NOTCH1
|
Health Risk |
Pathogenic |
Abnormal cardiovascular system morphology, Abnormal cardiovascular system morphology |
| RS2540423602 |
POC1B
|
Health Risk |
Pathogenic |
— |
| RS2540423816 |
ACBD5
|
Health Risk |
Likely pathogenic |
— |
| RS2540424549 |
TBX5
|
Health Risk |
Likely pathogenic |
Cardiovascular phenotype, Aortic valve disease 2 |
| RS2540425164 |
TBX5
|
Health Risk |
Likely pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |